EIF2AK2 and cancer: In healthy cells, OVs entering via growth factor receptors activate RAS/PKR pathways to inhibit protein translation; in tumor cells, PKR activation is blocked, making cancer cells more susceptible to OVs (Fig. 2b) [107,108].